Cargando…

Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins

Emerging viruses such as severe fever and thrombocytopenia syndrome virus (SFTSV) and Ebola virus (EBOV) are responsible for significant morbidity and mortality. Host cell proteases that process the glycoproteins of these viruses are potential targets for antiviral intervention. The aspartyl proteas...

Descripción completa

Detalles Bibliográficos
Autores principales: Plegge, Teresa, Spiegel, Martin, Krüger, Nadine, Nehlmeier, Inga, Winkler, Michael, González Hernández, Mariana, Pöhlmann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459477/
https://www.ncbi.nlm.nih.gov/pubmed/30973897
http://dx.doi.org/10.1371/journal.pone.0214968
_version_ 1783410184293449728
author Plegge, Teresa
Spiegel, Martin
Krüger, Nadine
Nehlmeier, Inga
Winkler, Michael
González Hernández, Mariana
Pöhlmann, Stefan
author_facet Plegge, Teresa
Spiegel, Martin
Krüger, Nadine
Nehlmeier, Inga
Winkler, Michael
González Hernández, Mariana
Pöhlmann, Stefan
author_sort Plegge, Teresa
collection PubMed
description Emerging viruses such as severe fever and thrombocytopenia syndrome virus (SFTSV) and Ebola virus (EBOV) are responsible for significant morbidity and mortality. Host cell proteases that process the glycoproteins of these viruses are potential targets for antiviral intervention. The aspartyl protease signal peptide peptidase (SPP) has recently been shown to be required for processing of the glycoprotein precursor, Gn/Gc, of Bunyamwera virus and for viral infectivity. Here, we investigated whether SPP is also required for infectivity of particles bearing SFTSV-Gn/Gc. Entry driven by the EBOV glycoprotein (GP) and the Lassa virus glycoprotein (LASV-GPC) depends on the cysteine proteases cathepsin B and L (CatB/CatL) and the serine protease subtilisin/kexin-isozyme 1 (SKI-1), respectively, and was examined in parallel for control purposes. We found that inhibition of SPP and SKI-1 did not interfere with SFTSV Gn + Gc-driven entry but, unexpectedly, blocked entry mediated by EBOV-GP. The inhibition occurred at the stage of proteolytic activation and the SPP inhibitor was found to block CatL/CatB activity. In contrast, the SKI-1 inhibitor did not interfere with CatB/CatL activity but disrupted CatB localization in endo/lysosomes, the site of EBOV-GP processing. These results underline the potential of protease inhibitors for antiviral therapy but also show that previously characterized compounds might exert broader specificity than initially appreciated and might block viral entry via diverse mechanisms.
format Online
Article
Text
id pubmed-6459477
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64594772019-05-03 Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins Plegge, Teresa Spiegel, Martin Krüger, Nadine Nehlmeier, Inga Winkler, Michael González Hernández, Mariana Pöhlmann, Stefan PLoS One Research Article Emerging viruses such as severe fever and thrombocytopenia syndrome virus (SFTSV) and Ebola virus (EBOV) are responsible for significant morbidity and mortality. Host cell proteases that process the glycoproteins of these viruses are potential targets for antiviral intervention. The aspartyl protease signal peptide peptidase (SPP) has recently been shown to be required for processing of the glycoprotein precursor, Gn/Gc, of Bunyamwera virus and for viral infectivity. Here, we investigated whether SPP is also required for infectivity of particles bearing SFTSV-Gn/Gc. Entry driven by the EBOV glycoprotein (GP) and the Lassa virus glycoprotein (LASV-GPC) depends on the cysteine proteases cathepsin B and L (CatB/CatL) and the serine protease subtilisin/kexin-isozyme 1 (SKI-1), respectively, and was examined in parallel for control purposes. We found that inhibition of SPP and SKI-1 did not interfere with SFTSV Gn + Gc-driven entry but, unexpectedly, blocked entry mediated by EBOV-GP. The inhibition occurred at the stage of proteolytic activation and the SPP inhibitor was found to block CatL/CatB activity. In contrast, the SKI-1 inhibitor did not interfere with CatB/CatL activity but disrupted CatB localization in endo/lysosomes, the site of EBOV-GP processing. These results underline the potential of protease inhibitors for antiviral therapy but also show that previously characterized compounds might exert broader specificity than initially appreciated and might block viral entry via diverse mechanisms. Public Library of Science 2019-04-11 /pmc/articles/PMC6459477/ /pubmed/30973897 http://dx.doi.org/10.1371/journal.pone.0214968 Text en © 2019 Plegge et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Plegge, Teresa
Spiegel, Martin
Krüger, Nadine
Nehlmeier, Inga
Winkler, Michael
González Hernández, Mariana
Pöhlmann, Stefan
Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
title Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
title_full Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
title_fullStr Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
title_full_unstemmed Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
title_short Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
title_sort inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459477/
https://www.ncbi.nlm.nih.gov/pubmed/30973897
http://dx.doi.org/10.1371/journal.pone.0214968
work_keys_str_mv AT pleggeteresa inhibitorsofsignalpeptidepeptidaseandsubtilisinkexinisozyme1inhibitebolavirusglycoproteindrivencellentrybyinterferingwithactivityandcellularlocalizationofendosomalcathepsins
AT spiegelmartin inhibitorsofsignalpeptidepeptidaseandsubtilisinkexinisozyme1inhibitebolavirusglycoproteindrivencellentrybyinterferingwithactivityandcellularlocalizationofendosomalcathepsins
AT krugernadine inhibitorsofsignalpeptidepeptidaseandsubtilisinkexinisozyme1inhibitebolavirusglycoproteindrivencellentrybyinterferingwithactivityandcellularlocalizationofendosomalcathepsins
AT nehlmeieringa inhibitorsofsignalpeptidepeptidaseandsubtilisinkexinisozyme1inhibitebolavirusglycoproteindrivencellentrybyinterferingwithactivityandcellularlocalizationofendosomalcathepsins
AT winklermichael inhibitorsofsignalpeptidepeptidaseandsubtilisinkexinisozyme1inhibitebolavirusglycoproteindrivencellentrybyinterferingwithactivityandcellularlocalizationofendosomalcathepsins
AT gonzalezhernandezmariana inhibitorsofsignalpeptidepeptidaseandsubtilisinkexinisozyme1inhibitebolavirusglycoproteindrivencellentrybyinterferingwithactivityandcellularlocalizationofendosomalcathepsins
AT pohlmannstefan inhibitorsofsignalpeptidepeptidaseandsubtilisinkexinisozyme1inhibitebolavirusglycoproteindrivencellentrybyinterferingwithactivityandcellularlocalizationofendosomalcathepsins